SCHEME 4. Amination of Aryl Halides
(5 mL). The combined organics assayed for 560 mg of the title
compound (77%). A pure analytical sample was obtained by
recrystallization from acetonitrile/water. Mp 109-111 °C; 1H NMR
(400 MHz, CDCl3) δH 7.32 (1 H, d, J ) 2.0 Hz), 7.17 (1 H, d, J
) 8.6 Hz), 7.01 (1 H, dd, J ) 2.0, 8.6 Hz), 3.83 (4 H, m), 3.70 (4
H, m); 13C NMR (100 MHz, CDCl3) δC 162.8, 147.4, 144.3, 129.4,
120.7, 116.6, 109.3, 66.1, 45.6; HRMS (ESI+) calcd for
C11H11ClN2O2 239.0587, found 239.0595.
General Procedure 1 for the Pd-Catalyzed Amination of
Benzoxazoles and Benzothiazoles. To a flask containing a
magnetic stir bar was added the aryl halide, sodium tert-butoxide,
Pd2dba3 ·CHCl3, ligand A, and amine in cases where this was solid.
The flask was evacuated and backfilled with nitrogen twice. The
amine was added with a syringe in cases where this was liquid
followed by toluene. The flask was evacuated and backfilled with
nitrogen twice, then heated to 90 °C for 16 h. The reaction mixture
was cooled to room temperature, then purified by silica gel
chromatography (100% hexane to 80% ethyl acetate in hexane) to
provide the products.
TABLE 2. Aminated Benzoxazoles/Benzothiazoles
(2-Morpholin-4-yl-benzothiazol-5-yl)-p-tolylamine (Table 2,
Entry 1). Following general procedure 1, 5-chloro-2-morpholin-
4-yl-benzothiazole (70 mg, 0.28 mmol), 4-methylaniline (35 mg,
0.33 mmol), sodium tert-butoxide (37 mg, 0.39 mmol),
Pd2dba3 ·CHCl3 (5.0 mg, 0.0055 mmol, 2 mol %), ligand A (10.5
mg, 0.0220 mmol, 8 mol %), and toluene (2 mL) were stirred at
90 °C for 16 h. After silica gel chromatography the title compound
was isolated as a pale brown solid (75.4 mg, 85%). Mp 163-168
1
°C; H NMR (400 MHz, CDCl3) δH 7.43 (1H, d, J ) 8.4 Hz),
7.29-7.26 (1H, m), 7.07 (2H, d, J ) 8.4 Hz), 7.01 (2H, d, J ) 8.4
Hz), 6.79 (1H, dd, J ) 8.4, 2.0 Hz), 5.67 (1H, br s), 3.84-3.80
(4H, m), 3.62-3.58 (4H, m), 2.30 (3H, s); 13C NMR (100 MHz,
CDCl3) δC 170.1, 153.9, 143.1, 140.7, 130.8, 130.0, 122.1, 121.2,
118.8, 112.9, 107.8, 66.4, 48.5, 20.8; HRMS (ESI+) calcd for
C18H19N3OS 326.1327, found 326.1313.
2-Morpholin-4-yl-5-pyridin-3-yl-benzoxazole (9). To a flask
containing a magnetic stir bar was added the 5-chloro-2-morpholin-
4-ylbenzoxazole (50 mg, 0.21 mmol), pyridine-3-boronic acid (39
mg, 0.31 mmol), potassium phosphate tribasic (89 mg, 0.42 mmol),
Pd2dba3 ·CHCl3 (1.9 mg, 0.0021 mmol, 1 mol %), and ligand A
(4.0 mg, 0.0084 mmol, 4 mol %). The flask was evacuated and
backfilled with nitrogen twice. n-Butanol (2 mL) was added then
flask was evacuated and backfilled with nitrogen twice and then
heated to 100 °C for 18 h. The reaction mixture was cooled to
room temperature, then filtered through a pad of Celite, eluting
with EtOAc. The solution was concentrated, then purified by silica
gel chromatography (100% hexane to 80% ethyl acetate in hexane)
to provide the title compound as a white solid (38.5 mg, 65%).
SCHEME 5. Suzuki coupling
for forcing conditions and/or the isolation of the unstable
chloride intermediates. Products bearing an aryl halide can be
further elaborated by using palladium-mediated reactions to
generate compounds of biological interest in a short and efficient
manner.
1
Mp 150-155 °C; H NMR (400 MHz, CDCl3) δH 8.85 (1H, d, J
) 1.6 Hz), 8.57 (1H, dd, J ) 4.8, 1.2 Hz), 7.87 (1H, dt, J ) 7.6,
1.6 Hz), 7.56 (1H, d, J ) 1.6 Hz), 7.38-7.34 (2H, m), 7.25 (1H,
dd, J ) 8.0, 1.6 Hz), 3.86-3.82 (4H, m), 3.74-3.71 (4H, m); 13
C
NMR (100 MHz, CDCl3) δC 162.8, 149.2, 147.7, 147.4, 144.1,
137.6, 135.4, 134.1, 124.0, 120.4, 115.3, 109.4, 66.3, 45.9; HRMS
(ESI+) calcd for C16H15N3O2 282.1243, found 282.1238.
Experimental Section
5-Chloro-2-morpholin-4-yl-1,3-benzoxazole (Table 1, Entry
1). To a mixture of 5-chloro-2-mercaptobenzoxazole (564 mg, 3.04
mmol) in dichloromethane (5 mL) was added oxalyl chloride (0.40
mL, 4.56 mmol). The reaction was cooled to 0 °C and N,N-
dimethylformamide (2 mL) was added dropwise at 0-5 °C. The
reaction was warmed to 20 °C, aged for 1 h, then recooled to 0 °C.
Triethylamine (1.27 mL, 9.12 mmol) was added dropwise at 0-10
°C followed by morpholine (0.29 mL, 3.34 mmol). The reaction
was warmed to 20 °C and aged for 1 h. The reaction was diluted
with water (5 mL) and dichloromethane (5 mL). The phases were
separated and the aqueous layer was extracted with dichloromethane
Acknowledgment. We thank Simon Hamilton and Alexia
Bertrand for mass spectrometry work.
Supporting Information Available: Experimental proce-
1
dures, characterization data, and copies of H and 13C NMR
spectra for all compounds. This material is available free of
JO900308T
J. Org. Chem. Vol. 74, No. 8, 2009 3231